FDA Inspection
TriRx Huntsville Pharmaceutical Services, LLCTriRx Huntsville Pharmaceutical Services, LLC – FDA Inspection, Aug 11, 2023
Record Details
This FDA Inspection record concerns TriRx Huntsville Pharmaceutical Services, LLC, with an inspection on August 11, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3b33daf8-bfa6-437e-9d8f-1611b733a98f
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1216782
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of TriRx Huntsville Pharmaceutical Services, LLC
13| Date | Classification | Office | Project area |
|---|---|---|---|
| June 15, 2026 | Not classified | New Orleans District Office | Drug Quality Assurance |
| April 1, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 21, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 19, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 1, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for TriRx Huntsville Pharmaceutical Services, LLC
- FDA Inspection 1322326 - 2026-06-15
- FDA Inspection 1166895 - 2022-04-01
- FDA Inspection 978625 - 2016-04-21
- FDA Inspection 908381 - 2014-12-19
- FDA Inspection 891076 - 2014-08-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.